Skip to main content
Fig. 5 | Journal for ImmunoTherapy of Cancer

Fig. 5

From: Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival

Fig. 5

Immunophenotypical aspects of high grade and stage IL-30Pos and IL-30Neg PC and prognostic evaluations. a Histologic (H&E) and immunohistochemical features of high grade and stage IL-30NegPC and IL-30PosPC. Magnification: X400. Scale bars: 30 μm. The inset shows TIA-1 (brown) co-localization with CD4 (red) (X1000). b Immune cell counts in high grade and stage IL-30NegPC and IL-30PosPC. c Kaplan–Meier estimates of BCR for stage III patients with Gleason score 8–10, classified as IL-30PosPC (n.25) and 30NegPC (n.59)

Back to article page